scholarly journals Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience

2012 ◽  
Vol 6 (2) ◽  
pp. 143-153 ◽  
Author(s):  
Michael B. Sprakes ◽  
Alexander C. Ford ◽  
Lisa Warren ◽  
Dan Greer ◽  
John Hamlin
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Infliximab Therapy ◽  
Single Centre ◽  
Predictors Of Response ◽  
Single Centre Experience

Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response

2008 ◽  
Vol 31 (7) ◽  
pp. 421-426 ◽  
Author(s):  
Yago González-Lama ◽  
Antonio López-San Román ◽  
Ignacio Marín-Jiménez ◽  
Begoña Casis ◽  
Isabel Vera ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Multicenter Study ◽  
Infliximab Therapy ◽  
Open Label ◽  
Predictors Of Response

scholarly journals P604 Adalimumab for the treatment of post-operative recurrence of Crohn's disease. A single centre experience

2013 ◽  
Vol 7 ◽  
pp. S252
Author(s):  
C. Praticò ◽  
F. Rizzello ◽  
A. Calafiore ◽  
C. Calabrese ◽  
G. Poggioli ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Single Centre ◽  
Single Centre Experience

Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience

2016 ◽  
Vol 44 (7) ◽  
pp. 673-683 ◽  
Author(s):  
T. Billiet ◽  
I. Cleynen ◽  
V. Ballet ◽  
M. Ferrante ◽  
G. Van Assche ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Prognostic Factors ◽  
Crohn's Disease ◽  
Infliximab Treatment ◽  
Single Centre ◽  
Single Centre Experience

Small bowel adenocarcinoma complicating Crohn’s disease: a single-centre experience emphasizing the importance of screening for dysplasia

2017 ◽  
Vol 471 (5) ◽  
pp. 611-617 ◽  
Author(s):  
Chloé Grolleau ◽  
Nicolas M. Pote ◽  
Nathalie S. Guedj ◽  
Magaly Zappa ◽  
Nathalie Theou-Anton ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Small Bowel Adenocarcinoma ◽  
Single Centre ◽  
Single Centre Experience

scholarly journals Comparative analysis of adverse events between infliximab and adalimumab in Crohn's disease management: a Brazilian single-centre experience

2013 ◽  
Vol 33 (1) ◽  
pp. 33-38 ◽  
Author(s):  
Paulo Gustavo Kotze ◽  
Fernando Kenji Akiyoshi ◽  
Mateus Luvizotto ◽  
Márcia Olandoski ◽  
Lorete Maria da Silva Kotze ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Comparative Analysis ◽  
Crohn's Disease ◽  
Disease Management ◽  
Adverse Events ◽  
Single Centre ◽  
Single Centre Experience
Sign in / Sign up

Export Citation Format

Share Document